图书馆订阅: Guest

Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer

卷 2, 册 1, 2011, pp. 89-94
DOI: 10.1615/ForumImmunDisTher.v2.i1.100
Get accessGet access

摘要

Raf kinase inhibitor protein (RKIP) is a small, cytosolic protein named for its ability to block Raf-mediated activation of MAPK and ERK. It also block G-protein signaling and NF-κB activation. An in vitro screen to identify genes that regulate prostate cancer (PCa) metastasis revealed that expression of RKIP was decreased in high versus low metastatic PCa cells. Modulation of RKIP expression revealed that it inhibited invasion and loss of RKIP promoted in vitro invasion. Animal studies were used to demonstrate that RKIP could inhibit PCa metastasis from orthotopically injected tumor cells without an effect on primary tumor growth. Taken together, these results indicated RKIP acted as a PCa metastasis suppressor gene. Evaluation of RKIP expression in clinical cases of PCa revealed that RKIP expression was moderate to high in non-neoplastic prostate, low in 50% of primary prostate cancers, and absent to low in the majority of metastases. Furthermore, low RKIP expression in primary prostate tumors was predictive of early tumor recurrence. Loss of RKIP was shown to induce resistance to radiation in PCa cells in vitro and in an in vivo murine model. Taken together, these studies indicate that RKIP plays multiple roles in PCa pathophysiology, suggesting that a method to increase RKIP expression in PCa may have therapeutic benefits.

对本文的引用
  1. Hao Chunfang, Wei Sen, Tong Zhongsheng, Li Shufen, Shi Yehui, Wang Xiaorui, Zhu Zhi-hua, The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro, Tumor Biology, 33, 4, 2012. Crossref

  2. Ben Jemaa Awatef, Bouraoui Yosra, Sallami Sataa, Nouira Yassine, Oueslati Ridha, A Comparison of the Biological Features of Prostate Cancer with (PSA+, PSMA+) Profile according to RKIP, BioMed Research International, 2013, 2013. Crossref

  3. Chen Yang, Xin Xianxiang, Li Jie, Xu Jianfeng, Yu Xiaoxiang, Li Tianyu, Mo Zengnan, Hu Yanling, Migliaccio Antimo, RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer, PLoS ONE, 8, 11, 2013. Crossref

  4. ZHAO DONGQIANG, MA JUNJI, SHI JUNLI, CHENG LIJUAN, LI FANGFANG, JIANG XIAOYU, JIANG HUIQING, Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression, Oncology Reports, 30, 1, 2013. Crossref

  5. Sittadjody Sivanandane, Thangasamy Thilakavathy, NickKolgh Bita, Balaji K. C., Non-androgen Signaling Pathways in Castration-Resistant Prostate Cancer, in Managing Metastatic Prostate Cancer In Your Urological Oncology Practice, 2016. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain